blincyto

Biotech Stock News (ANAC) (CELG) (RCPT) (JUNO) – CNA Finance

Anacor Pharmaceuticals (NASDAQ:ANAC)On Monday July 13, 2015 shares of Anacor went up 55%, closing around $131.93 per share after the company announced positive phase 3 results in patients who have atopic dermatitis. There were two phase 3 trials that were testing Anacor’s drug, Crisaborole, for these patients with atopic dermatitis — also known as Eczema. The company wanted to see […]